The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Morphine Sulphate Market Research Report 2025
Synopsis
Morphine sulfate extended-release tablets are powerful analgesics, mainly suitable for analgesia in patients with severe cancer pain
Global Morphine Sulphate market is projected to reach US$ 2798.6 million in 2029, increasing from US$ 1633 million in 2022, with the CAGR of 8.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Morphine Sulphate market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Morphine Sulphate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Mundi Pharma
Bard Pharma
Qinhai Zhiyao
Nepharm
Mayinglong
Padagis
Piramal Enterprises
Actavis
Akacia Healthcare
AbbVie
Allied Drug
Angelini Pharma
ANI Pharma
Apotex
Arrow Pharma
Hameln Pharma
Pfizer Inc.
Fresenius Kabi
Segment by Type
Tablets
Solution for Injection
Oral Liquid
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Morphine Sulphate report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Morphine sulfate extended-release tablets are powerful analgesics, mainly suitable for analgesia in patients with severe cancer pain
Global Morphine Sulphate market is projected to reach US$ 2798.6 million in 2029, increasing from US$ 1633 million in 2022, with the CAGR of 8.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Morphine Sulphate market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Morphine Sulphate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Mundi Pharma
Bard Pharma
Qinhai Zhiyao
Nepharm
Mayinglong
Padagis
Piramal Enterprises
Actavis
Akacia Healthcare
AbbVie
Allied Drug
Angelini Pharma
ANI Pharma
Apotex
Arrow Pharma
Hameln Pharma
Pfizer Inc.
Fresenius Kabi
Segment by Type
Tablets
Solution for Injection
Oral Liquid
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Morphine Sulphate report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Morphine Sulphate Market Overview
1.1 Product Overview and Scope of Morphine Sulphate
1.2 Morphine Sulphate Segment by Type
1.2.1 Global Morphine Sulphate Market Value Comparison by Type (2023-2029)
1.2.2 Tablets
1.2.3 Solution for Injection
1.2.4 Oral Liquid
1.3 Morphine Sulphate Segment by Application
1.3.1 Global Morphine Sulphate Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Morphine Sulphate Market Size Estimates and Forecasts
1.4.1 Global Morphine Sulphate Revenue 2018-2029
1.4.2 Global Morphine Sulphate Sales 2018-2029
1.4.3 Global Morphine Sulphate Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Morphine Sulphate Market Competition by Manufacturers
2.1 Global Morphine Sulphate Sales Market Share by Manufacturers (2018-2023)
2.2 Global Morphine Sulphate Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Morphine Sulphate Average Price by Manufacturers (2018-2023)
2.4 Global Morphine Sulphate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Morphine Sulphate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Morphine Sulphate, Product Type & Application
2.7 Morphine Sulphate Market Competitive Situation and Trends
2.7.1 Morphine Sulphate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Morphine Sulphate Players Market Share by Revenue
2.7.3 Global Morphine Sulphate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Morphine Sulphate Retrospective Market Scenario by Region
3.1 Global Morphine Sulphate Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Morphine Sulphate Global Morphine Sulphate Sales by Region: 2018-2029
3.2.1 Global Morphine Sulphate Sales by Region: 2018-2023
3.2.2 Global Morphine Sulphate Sales by Region: 2024-2029
3.3 Global Morphine Sulphate Global Morphine Sulphate Revenue by Region: 2018-2029
3.3.1 Global Morphine Sulphate Revenue by Region: 2018-2023
3.3.2 Global Morphine Sulphate Revenue by Region: 2024-2029
3.4 North America Morphine Sulphate Market Facts & Figures by Country
3.4.1 North America Morphine Sulphate Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Morphine Sulphate Sales by Country (2018-2029)
3.4.3 North America Morphine Sulphate Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Morphine Sulphate Market Facts & Figures by Country
3.5.1 Europe Morphine Sulphate Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Morphine Sulphate Sales by Country (2018-2029)
3.5.3 Europe Morphine Sulphate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Morphine Sulphate Market Facts & Figures by Country
3.6.1 Asia Pacific Morphine Sulphate Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Morphine Sulphate Sales by Country (2018-2029)
3.6.3 Asia Pacific Morphine Sulphate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Morphine Sulphate Market Facts & Figures by Country
3.7.1 Latin America Morphine Sulphate Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Morphine Sulphate Sales by Country (2018-2029)
3.7.3 Latin America Morphine Sulphate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Morphine Sulphate Market Facts & Figures by Country
3.8.1 Middle East and Africa Morphine Sulphate Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Morphine Sulphate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Morphine Sulphate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Morphine Sulphate Sales by Type (2018-2029)
4.1.1 Global Morphine Sulphate Sales by Type (2018-2023)
4.1.2 Global Morphine Sulphate Sales by Type (2024-2029)
4.1.3 Global Morphine Sulphate Sales Market Share by Type (2018-2029)
4.2 Global Morphine Sulphate Revenue by Type (2018-2029)
4.2.1 Global Morphine Sulphate Revenue by Type (2018-2023)
4.2.2 Global Morphine Sulphate Revenue by Type (2024-2029)
4.2.3 Global Morphine Sulphate Revenue Market Share by Type (2018-2029)
4.3 Global Morphine Sulphate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Morphine Sulphate Sales by Application (2018-2029)
5.1.1 Global Morphine Sulphate Sales by Application (2018-2023)
5.1.2 Global Morphine Sulphate Sales by Application (2024-2029)
5.1.3 Global Morphine Sulphate Sales Market Share by Application (2018-2029)
5.2 Global Morphine Sulphate Revenue by Application (2018-2029)
5.2.1 Global Morphine Sulphate Revenue by Application (2018-2023)
5.2.2 Global Morphine Sulphate Revenue by Application (2024-2029)
5.2.3 Global Morphine Sulphate Revenue Market Share by Application (2018-2029)
5.3 Global Morphine Sulphate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Mundi Pharma
6.1.1 Mundi Pharma Corporation Information
6.1.2 Mundi Pharma Description and Business Overview
6.1.3 Mundi Pharma Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Mundi Pharma Morphine Sulphate Product Portfolio
6.1.5 Mundi Pharma Recent Developments/Updates
6.2 Bard Pharma
6.2.1 Bard Pharma Corporation Information
6.2.2 Bard Pharma Description and Business Overview
6.2.3 Bard Pharma Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bard Pharma Morphine Sulphate Product Portfolio
6.2.5 Bard Pharma Recent Developments/Updates
6.3 Qinhai Zhiyao
6.3.1 Qinhai Zhiyao Corporation Information
6.3.2 Qinhai Zhiyao Description and Business Overview
6.3.3 Qinhai Zhiyao Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Qinhai Zhiyao Morphine Sulphate Product Portfolio
6.3.5 Qinhai Zhiyao Recent Developments/Updates
6.4 Nepharm
6.4.1 Nepharm Corporation Information
6.4.2 Nepharm Description and Business Overview
6.4.3 Nepharm Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nepharm Morphine Sulphate Product Portfolio
6.4.5 Nepharm Recent Developments/Updates
6.5 Mayinglong
6.5.1 Mayinglong Corporation Information
6.5.2 Mayinglong Description and Business Overview
6.5.3 Mayinglong Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mayinglong Morphine Sulphate Product Portfolio
6.5.5 Mayinglong Recent Developments/Updates
6.6 Padagis
6.6.1 Padagis Corporation Information
6.6.2 Padagis Description and Business Overview
6.6.3 Padagis Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Padagis Morphine Sulphate Product Portfolio
6.6.5 Padagis Recent Developments/Updates
6.7 Piramal Enterprises
6.6.1 Piramal Enterprises Corporation Information
6.6.2 Piramal Enterprises Description and Business Overview
6.6.3 Piramal Enterprises Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Piramal Enterprises Morphine Sulphate Product Portfolio
6.7.5 Piramal Enterprises Recent Developments/Updates
6.8 Actavis
6.8.1 Actavis Corporation Information
6.8.2 Actavis Description and Business Overview
6.8.3 Actavis Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Actavis Morphine Sulphate Product Portfolio
6.8.5 Actavis Recent Developments/Updates
6.9 Akacia Healthcare
6.9.1 Akacia Healthcare Corporation Information
6.9.2 Akacia Healthcare Description and Business Overview
6.9.3 Akacia Healthcare Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Akacia Healthcare Morphine Sulphate Product Portfolio
6.9.5 Akacia Healthcare Recent Developments/Updates
6.10 AbbVie
6.10.1 AbbVie Corporation Information
6.10.2 AbbVie Description and Business Overview
6.10.3 AbbVie Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AbbVie Morphine Sulphate Product Portfolio
6.10.5 AbbVie Recent Developments/Updates
6.11 Allied Drug
6.11.1 Allied Drug Corporation Information
6.11.2 Allied Drug Morphine Sulphate Description and Business Overview
6.11.3 Allied Drug Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Allied Drug Morphine Sulphate Product Portfolio
6.11.5 Allied Drug Recent Developments/Updates
6.12 Angelini Pharma
6.12.1 Angelini Pharma Corporation Information
6.12.2 Angelini Pharma Morphine Sulphate Description and Business Overview
6.12.3 Angelini Pharma Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Angelini Pharma Morphine Sulphate Product Portfolio
6.12.5 Angelini Pharma Recent Developments/Updates
6.13 ANI Pharma
6.13.1 ANI Pharma Corporation Information
6.13.2 ANI Pharma Morphine Sulphate Description and Business Overview
6.13.3 ANI Pharma Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.13.4 ANI Pharma Morphine Sulphate Product Portfolio
6.13.5 ANI Pharma Recent Developments/Updates
6.14 Apotex
6.14.1 Apotex Corporation Information
6.14.2 Apotex Morphine Sulphate Description and Business Overview
6.14.3 Apotex Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Apotex Morphine Sulphate Product Portfolio
6.14.5 Apotex Recent Developments/Updates
6.15 Arrow Pharma
6.15.1 Arrow Pharma Corporation Information
6.15.2 Arrow Pharma Morphine Sulphate Description and Business Overview
6.15.3 Arrow Pharma Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Arrow Pharma Morphine Sulphate Product Portfolio
6.15.5 Arrow Pharma Recent Developments/Updates
6.16 Hameln Pharma
6.16.1 Hameln Pharma Corporation Information
6.16.2 Hameln Pharma Morphine Sulphate Description and Business Overview
6.16.3 Hameln Pharma Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Hameln Pharma Morphine Sulphate Product Portfolio
6.16.5 Hameln Pharma Recent Developments/Updates
6.17 Pfizer Inc.
6.17.1 Pfizer Inc. Corporation Information
6.17.2 Pfizer Inc. Morphine Sulphate Description and Business Overview
6.17.3 Pfizer Inc. Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Pfizer Inc. Morphine Sulphate Product Portfolio
6.17.5 Pfizer Inc. Recent Developments/Updates
6.18 Fresenius Kabi
6.18.1 Fresenius Kabi Corporation Information
6.18.2 Fresenius Kabi Morphine Sulphate Description and Business Overview
6.18.3 Fresenius Kabi Morphine Sulphate Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Fresenius Kabi Morphine Sulphate Product Portfolio
6.18.5 Fresenius Kabi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Morphine Sulphate Industry Chain Analysis
7.2 Morphine Sulphate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Morphine Sulphate Production Mode & Process
7.4 Morphine Sulphate Sales and Marketing
7.4.1 Morphine Sulphate Sales Channels
7.4.2 Morphine Sulphate Distributors
7.5 Morphine Sulphate Customers
8 Morphine Sulphate Market Dynamics
8.1 Morphine Sulphate Industry Trends
8.2 Morphine Sulphate Market Drivers
8.3 Morphine Sulphate Market Challenges
8.4 Morphine Sulphate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
